MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma
Authors
Keywords
-
Journal
CANCER
Volume 123, Issue 6, Pages 1061-1070
Publisher
Wiley
Online
2016-12-08
DOI
10.1002/cncr.30437
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment
- (2016) E. An et al. ANNALS OF ONCOLOGY
- MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
- (2016) Mark M. Awad et al. JOURNAL OF CLINICAL ONCOLOGY
- Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH
- (2015) Daniel V. T. Catenacci et al. Gastric Cancer
- MET in gastric cancer - discarding a 10% cutoff rule
- (2015) Marie-Luise Metzger et al. HISTOPATHOLOGY
- Phase I study of ABT-700, an anti-c-Met antibody, in patients (pts) with advanced gastric or esophageal cancer (GEC).
- (2015) Yoon-Koo Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical activity of AMG 337, an oral MET kinase inhibitor, in adult patients (pts) with MET-amplified gastroesophageal junction (GEJ), gastric (G), or esophageal (E) cancer.
- (2015) Eunice Lee Kwak et al. JOURNAL OF CLINICAL ONCOLOGY
- High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy
- (2015) Paolo Nuciforo et al. Molecular Oncology
- Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping
- (2015) P. K. Paik et al. Cancer Discovery
- Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors
- (2015) G. M. Frampton et al. Cancer Discovery
- HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development
- (2015) Stephen P. Hack et al. Oncotarget
- Analysis of 1,115 Patients Tested for MET Amplification and Therapy Response in the MD Anderson Phase I Clinic
- (2014) D. L. F. Jardim et al. CLINICAL CANCER RESEARCH
- Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study
- (2014) Timothy Iveson et al. LANCET ONCOLOGY
- Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity
- (2014) Daniel V.T. Catenacci Molecular Oncology
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Absolute Quantitation of Met Using Mass Spectrometry for Clinical Application: Assay Precision, Stability, and Correlation with MET Gene Amplification in FFPE Tumor Tissue
- (2014) Daniel V. T. Catenacci et al. PLoS One
- Analysis of MET mRNA Expression in Gastric Cancers Using RNA In Situ Hybridization Assay: Its Clinical Implication and Comparison with Immunohistochemistry and Silver In Situ Hybridization
- (2014) Jiwoon Choi et al. PLoS One
- Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
- (2013) L. Goyal et al. CLINICAL CANCER RESEARCH
- Application of Selected Reaction Monitoring for Multiplex Quantification of Clinically Validated Biomarkers in Formalin-Fixed, Paraffin-Embedded Tumor Tissue
- (2013) Todd Hembrough et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors
- (2013) E. Penuel et al. MOLECULAR CANCER THERAPEUTICS
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
- (2013) Manish A. Shah et al. PLoS One
- c-Met as a Prognostic Marker in Gastric Cancer: A Systematic Review and Meta-Analysis
- (2013) Shan Yu et al. PLoS One
- Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
- (2013) Alberto Bardelli et al. Cancer Discovery
- cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival Outcomes
- (2012) K. P. Raghav et al. CLINICAL CANCER RESEARCH
- Targeting the HGF/Met signaling pathway in cancer therapy
- (2012) Fabiola Cecchi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- RON(MST1R)is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma
- (2011) Daniel V.T. Catenacci et al. CANCER BIOLOGY & THERAPY
- Genetic Activation of theMETPathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer
- (2011) Francesco Graziano et al. JOURNAL OF CLINICAL ONCOLOGY
- METAmplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
- (2011) Jochen K. Lennerz et al. JOURNAL OF CLINICAL ONCOLOGY
- RNAscope
- (2011) Fay Wang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Durable Complete Response of Metastatic Gastric Cancer with Anti-Met Therapy Followed by Resistance at Recurrence
- (2011) D. V. T. Catenacci et al. Cancer Discovery
- Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion
- (2010) Yoshinari Asaoka et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- IncreasedMETGene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
- (2009) Federico Cappuzzo et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started